{
 "awd_id": "0078548",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase II:   Antigen-Mediated Selection of Hybridomas",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Om P. Sahai",
 "awd_eff_date": "2000-10-01",
 "awd_exp_date": "2003-09-30",
 "tot_intn_awd_amt": 400000.0,
 "awd_amount": 510714.0,
 "awd_min_amd_letter_date": "2000-09-12",
 "awd_max_amd_letter_date": "2003-01-10",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase II project aims to develop a rapid, sensitive and highly specific method for monoclonal antibody production and hybridoma cell line development by combining single\r\ncell gel microdrop (GMD) encapsulation technology, a novel protein capture format, and fluorescence activated cell sorting.  Using insulin as a model antigen, Phase I studies demonstrated that individual cells,\r\nwhich comprised a 1% sub-population of a heterogeneous population, could be rapidly isolated based on both secretion level and antigen specificity of the secreted antibody.  Phase II research will optimize the assay format by permitting simultaneous analysis of other antibody properties, including antibody isotype and blocking properties.  Using newly fused hybridomas, Phase II research will isolate and enrich productive\r\nclones and compare results with conventional methods which require use of time consuming and labor intensive limiting dilution cloning.\r\n\r\nMonoclonal antibodies are widely used as research, therapeutic, diagnostic, and imaging reagents, and are increasingly used in the emerging field of proteomics for discovering new drug targets and locating disease specific markers. The GMD method will reduce production time and costs, improve antibody quality and yield, and permit isolation of rare cells.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Yevgenya",
   "pi_last_name": "Akselband",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Yevgenya Akselband",
   "pi_email_addr": "yaks@onecell.com",
   "nsf_id": "000095175",
   "pi_start_date": "2000-09-12",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "ONE CELL SYSTEMS, INC",
  "inst_street_address": "100 INMAN ST STE 200",
  "inst_street_address_2": "",
  "inst_city_name": "CAMBRIDGE",
  "inst_state_code": "MA",
  "inst_state_name": "Massachusetts",
  "inst_phone_num": "6178682399",
  "inst_zip_code": "021399129",
  "inst_country_name": "United States",
  "cong_dist_code": "07",
  "st_cong_dist_code": "MA07",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "ONE CELL SYSTEMS, INC",
  "perf_str_addr": "100 INMAN ST STE 200",
  "perf_city_name": "CAMBRIDGE",
  "perf_st_code": "MA",
  "perf_st_name": "Massachusetts",
  "perf_zip_code": "021399129",
  "perf_ctry_code": "US",
  "perf_cong_dist": "07",
  "perf_st_cong_dist": "MA07",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537300",
   "pgm_ele_name": "SBIR Phase II"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "1136",
   "pgm_ref_txt": "SIGNAL TRANSDCTN/CELL REGULATN"
  },
  {
   "pgm_ref_code": "9102",
   "pgm_ref_txt": "WOMEN, MINORITY, DISABLED, NEC"
  },
  {
   "pgm_ref_code": "9178",
   "pgm_ref_txt": "UNDERGRADUATE EDUCATION"
  },
  {
   "pgm_ref_code": "9183",
   "pgm_ref_txt": "GENERAL FOUNDATIONS OF BIOTECHNOLOGY"
  },
  {
   "pgm_ref_code": "9231",
   "pgm_ref_txt": "SUPPL FOR UNDERGRAD RES ASSIST"
  },
  {
   "pgm_ref_code": "9251",
   "pgm_ref_txt": "REU SUPP-Res Exp for Ugrd Supp"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0100",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0100",
   "fund_name": "",
   "fund_symb_id": ""
  },
  {
   "app_code": "0101",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01000102DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  },
  {
   "app_code": "0102",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0102",
   "fund_name": "",
   "fund_symb_id": ""
  },
  {
   "app_code": "0103",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0103",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2000,
   "fund_oblg_amt": 362914.0
  },
  {
   "fund_oblg_fiscal_yr": 2001,
   "fund_oblg_amt": 6000.0
  },
  {
   "fund_oblg_fiscal_yr": 2002,
   "fund_oblg_amt": 129800.0
  },
  {
   "fund_oblg_fiscal_yr": 2003,
   "fund_oblg_amt": 12000.0
  }
 ],
 "por": null
}